Expression of CDX2, CK20 and CK7 in the epithelium of the gastric mucosa in schoolchildren with CagA H. pylori-associated gastritis

Aim. To study the association of protein expression CDX2, CK20, CK7 in the epithelium of the gastric mucosa in schoolchildren with CagA H. pylori-associated gastritis. Material and methods. Gastroscopy was performed with the collection of biopsy material from the mucous membrane of the antrum and body of the stomach in 89 schoolchildren (7-17 years old) with gastroenterological complaints. The morphological method confirmed the diagnosis of gastritis and determined the presence of H. pylori. Gastric biopsies were examined immunohistochemically to identify the proteins CDX2, CK20, CK7 in the epithelium. Blood was also collected to determine the CagA strain of H. pylori using enzyme immunoassay. Results. In schoolchildren infected with CagA H. pylori, higher expression of CK7 was found in both parts of the stomach (in the body (p = 0.044), in the antrum (p = 0.014)) compared to uninfected children. Changes in the expression of CDX2 and CK20 in children infected with H. pylori CagA have not been established. CDX2 protein was detected more often among schoolchildren aged 12-17 years with H. pylori infection than in children without H. pylori (p = 0.062) and in children with CagA H. pylori (p = 0.017). In the group of younger children with CagA H. pylori, there were higher levels of CK7 expression in the epithelium of the antrum of the stomach, compared with uninfected children (p = 0.033). They also had higher CK7 in the body than in CagA H. pylori-associated gastritis in children of the older age group (p = 0.001). Boys with CagA H. pylori had the highest expression of CK7 in the gastric body, which was higher than in uninfected boys (p = 0.021). Conclusion. Thus, in children, the features of the association of CDX2, CK20, CK7 with CagA H. pylori-associated gastritis have been established, including depending on the age and gender of the child.

children, gastritis, biomarkers, CagA H. pylori, cytokeratins

1. Ivashkin V.T., Maev I. V., Gorgun J. V. et al. Pathogenetic treatment of gastritis as a basis for the prevention of gastric cancer in the countries of the Commonwealth of Independent States: literature review and the resolution of a scientific symposium held in Minsk, Republic of Belarus, january, 27, 2018.Rus J Gastroenterol Hepatol Coloproctol. 2018; 28(4): 7-14. (In Russ.) doi: 10.22416/1382-4376-2018-28-4-7-14.@@ Ивашкин В. Т., Маев И. В., Горгун Ю. В. и др. Патогенетическое лечение гастрита как основа профилактики рака желудка в странах - членах Содружества Независимых Государств (Обзор литературы и резолюция научного симпозиума 27.01.2018, г. Минск, Республика Беларусь). Рос журн гастроэнтерол гепатол колопроктол. 2018; 28(4): 7-14. doi: 10.22416/1382-4376-2018-28-4-7-14

2. Zhang Y. H., Chen X. L., Wang Y. R. et al. Prevention of malignant digestive system tumors should focus on the control of chronic inflammation. World J Gastrointest Oncol. 2023; 15(3): 389-404. doi: 10.4251/wjgo.v15.i3.389.

3. Abbas M., Habib M., Naveed M. et al. The relevance of gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice. Biomed Pharmacother. 2017; 95: 1082-1090. doi: 10.1016/j.biopha.2017.09.032.

4. Negovan A., Iancu M., Fülöp E., Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol. 2019; 25(30): 4105-4124. doi: 10.3748/wjg.v25.i30.4105.

5. George S., Lucero Y., Torres J. P. et al. Gastric Damage and Cancer-Associated Biomarkers in Helicobacter pylori-Infected Children. Front Microbiol. 2020; 11: 90. doi: 10.3389/fmicb.2020.00090.

6. Waddingham W., Nieuwenburg S. A.V., Carlson S. et al. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol. 2020; 12(4): 322-331. doi: 10.1136/flgastro-2018-101089.

7. Kharitonovа L. A., Grigoriev K. I., Zaprudnov A. M. From an idea to realities: modern successes of children’s gastroenterology. Experimental and Clinical Gastroenterology. 2019; 171(11): 4-15. (In Russ.) doi: 10.31146/1682-8658-ecg-171-11-4-15.@@ Харитонова Л. А., Григорьев К. И., Запруднов А. М. От идеи к реалиям: современные успехи детской гастроэнтерологии. Экспериментальная и клиническая гастроэнтерология. 2019; 171(11): 4-15. doi: 10.31146/1682-8658-ecg-171-11-4-15.

8. Polivanova T. V., Vshivkov V. A., Muravieva N. G. Architectonic histology of collagen fibers in stomach mucosa in schoolchildren with dyspepsia syndrome. Transbaikalian Medical Bulletin. 2015; 2: 94-98. (in Russ.)@@ Поливанова Т. В., Вшивков В. А., Муравьева Н. Г. Гистоархитектоника коллагеновых волокон в слизистой желудка у школьников с синдромом диспепсии. Забайкальский медицинский вестник. 2015; 2: 94-98.

9. Ye D. M., Xu G., Ma W. et al. Significant function and research progress of biomarkers in gastric cancer. Oncol Lett. 2020; 19(1): 17-29. doi: 10.3892/ol.2019.11078.

10. Nayak J., Mohanty P., Lenka A. et al. Histopathological and Immunohistochemical Evaluation of CDX2 and Ki67 in Colorectal Lesions with their Expression Pattern in Different Histologic Variants, Grade, and Stage of Colorectal Carcinomas. J Microsc Ultrastruct. 2021; 9(4): 183-189. doi: 10.4103/JMAU.JMAU_69_20.

11. Villarreal-Calderon R., Luévano-González A., Aragón-Flores M. et al. Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis. Ann Diagn Pathol. 2014; 18(3):129-35.

12. Němejcová K., Šafanda A., Bártů M. K. et al. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors. Diagn Pathol. 2023; 18(1): 32. doi: 10.1186/s13000-023-01317-9.

13. Vernygorodskyi S. V. Molecular and biological markers in the diagnosis and prognosis of the gastric mucosa intestinal meta_plasia. Ros Med-Bio. Vestn. 2013; 21(1): 11-17. (In Russ.)@@ Вернигородский С. В. Молекулярно-биологические маркеры в диагностике и прогнозе кишечной метаплазии слизистой оболочки желудка. Российский медико-биологический вестник им. академика И. П. Павлова. 2013; 1: 11-17.

14. Todorovic V., Sokic-Milutinovic A., Drndarevic N. et al. Expression of cytokeratins in Helicobacter pylori-associated chronic gastritis of adult patients infected with cagA+ strains: an immunohistochemical study. World J Gastroenterol. 2006; 12(12): 1865-73.

15. Dixon M. F., Genta R. M., Yardley J. H. Histological classification of gastritis and Helicobacter pylori infection: an agreement at last? The International Workshop on the Histopathology of Gastritis. Helicobacter. 1997; 2(1):17-24.

16. Sugano K., Tack J., Kuipers E. J. et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015; 64(9): 1353-1367. doi: 10.1136/gutjnl-2015-309252.

17. Parygina M. N., Mozgovoi S. I., Shimanskaya A. G., Kononov A. V. CDX2 Protein as a Surrogate Marker of Gastric Mucosal Atrophy. Journal of Anatomy and Histopathology. 2021; 10(3): 60-67. (In Russ.) doi: 10.18499/2225-7357-2021-10-3-60-67.@@ Парыгина М. Н., Мозговой С. И., Шиманская А. Г., Кононов А. В. Белок CDX2 как суррогатный маркер атрофии слизистой оболочки желудка. Журнал анатомии и гистопатологии. 2021; 10(3): 60-67. doi: 10.18499/2225-7357-2021-10-3-60-67.

18. Chu P., Wu E., Weiss L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000; 13(9): 962-72. doi: 10.1038/modpathol.3880175.

19. Xu Y., Wang W., Li L. et al. FOXA1 and CK7 expression in esophageal squamous cell carcinoma and its prognostic significance. Neoplasma. 2018; 65(3): 469-476. doi: 10.4149/neo_2018_170529N384.